Modafinil, a wakefulness-promoting agent, has gained considerable consideration since its approval by the U.S. Meals and Drug Administration (FDA) in 1998 for the treatment of narcolepsy. Originally developed for patients affected by excessive daytime sleepiness, modafinil has since discovered its…